R-Pharm LLC, a resident of the Pirallahi Industrial Park, for the first time in our country launched the production of the drug Diabeton® MR (gliclazide) for the prevention of complications of diabetes mellitus. The Company has already produced and sent 200,000 boxes of drugs to appropriate distribution locations. The Company is going to produce an additional 300,000 boxes of Diabeton® MR by the end of the first quarter of this year.

Note that the drug is manufactured under a partnership agreement concluded by and between R-Pharm LLC and the French international pharmaceutical group Servier. The terms of the five-year agreement say that the Company plans to produce about 1 million boxes of the drug per year.

Please be informed that the manufacturing process at R-Pharm LLC complies with international GMP standards. The international GMP standards impose strict requirements on pharmaceutical manufacturers, such as the use of high quality raw materials and modern processing technologies, the availability of advanced equipment, and a high level of specialization of manufacturing personnel. R-Pharm LLC is the first pharmaceutical company in the country to receive a GMP Certificate